{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:30:43Z","timestamp":1793583043466,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Hellenic Institute for the Study of Sepsis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-1977-1","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T14:43:14Z","timestamp":1520001794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Increases in inflammatory and CD14dim\/CD16pos\/CD45pos patrolling monocytes in sepsis: correlation with final outcome"],"prefix":"10.1186","volume":"22","author":[{"given":"Gabriela","family":"Gainaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraklis","family":"Tsangaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malvina","family":"Lada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Pistiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,3]]},"reference":[{"key":"1977_CR1","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS. Immunosupression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594\u2013605.","journal-title":"JAMA."},{"key":"1977_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1189\/jlb.0806510","volume":"81","author":"L Zeigler-Heitbrock","year":"2007","unstructured":"Zeigler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81:584\u201392.","journal-title":"J Leukoc Biol."},{"key":"1977_CR3","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, Anucuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74\u201380.","journal-title":"Blood."},{"key":"1977_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fimmu.2016.00322","volume":"7","author":"H Lund","year":"2016","unstructured":"Lund H, Boysen P, Akesson CP, Lewandowska-Sabat AM, Storset AK. Transient migration of large numbers of CD14(++)CD16(+) monocytes to the draining lymph node after onset of inflammation. Front Immunol. 2016;7:322.","journal-title":"Front Immunol."},{"key":"1977_CR5","doi-asserted-by":"publisher","first-page":"13886","DOI":"10.1038\/srep13886","volume":"5","author":"R Mukherjee","year":"2015","unstructured":"Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B. Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematosus. Sci Rep. 2015;5:13886.","journal-title":"Sci Rep."},{"key":"1977_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1160\/TH16-05-0405","volume":"116","author":"KA Krychtiuk","year":"2016","unstructured":"Krychtiuk KA, Lenz M, Koller L, Honeder MC, Wutzlhofer L, Zhang C, Chi L, Maurer G, Niessner A, Huber K, Wojta J, Heinz G, Speidl WS. Monocyte subset is associated with mortality in critically ill patients. Thromb Haemost. 2016;116:949\u201357.","journal-title":"Thromb Haemost."},{"key":"1977_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/jac\/dkt475","volume":"69","author":"EJ Giamarellos-Bourboulis","year":"2014","unstructured":"Giamarellos-Bourboulis EJ, Mylona V, Antonopoulou A, Tsangaris I, Koutelidakis I, Marioli A, Raftogiannis M, Kopterides P, Lymberopoulou K, Mouktaroudi M, Papageorgiou C, Papaziogas B, Georgopoulou AP, Tsaganos T, Papadomichelakis E, Gogos C, Ladas M, Savva A, Pelekanou A, Baziaka F, Koutoukas P, Kanni T, Spyridaki A, Maniatis N, Pelekanos N, Kotsaki A, Vaki I, Douzinas EE, Koratzanis G, Armaganidis A. Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. J Antimicrob Chemother. 2014;69:1111\u20138.","journal-title":"J Antimicrob Chemother."},{"key":"1977_CR8","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definition Conference. Crit Care Med. 2003;31:1250\u20136.","journal-title":"Crit Care Med."},{"key":"1977_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cyto.2017.01.012","volume":"92","author":"P Papadopoulos","year":"2017","unstructured":"Papadopoulos P, Pistiki A, Theodorakopoulou M, Christodoulopoulou T, Damoraki G, Goukos D, Briassouli E, Dimopoulou I, Armaganidis A, Nanas S, Briassoulis G, Tsiodras S. Immunoparalysis: clinical and immunological associations in SIRS and severe sepsis patients. Cytokine. 2017;92:83\u201392.","journal-title":"Cytokine."},{"key":"1977_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/cc10452","volume":"15","author":"G Monneret","year":"2011","unstructured":"Monneret G, Lepape A, Venet F. A dynamic view of mHLA-DR expression in management of severe septic patients. Crit Care. 2011;15:198.","journal-title":"Crit Care."},{"key":"1977_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/cyto.b.21270","volume":"90","author":"G Monneret","year":"2016","unstructured":"Monneret G, Venet F. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy. Cytometry B Clin Cytom. 2016;90:376\u201386.","journal-title":"Cytometry B Clin Cytom."},{"key":"1977_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13054-016-1505-0","volume":"20","author":"AM Drewry","year":"2016","unstructured":"Drewry AM, Ablordeppey EA, Murray ET, Beiter ER, Walton AH, Hall MW, Hotchkiss RS. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor-alpha production as outcome predictors in severe sepsis: a prospective observational study. Crit Care. 2016;20:334.","journal-title":"Crit Care."},{"key":"1977_CR13","doi-asserted-by":"publisher","first-page":"R220","DOI":"10.1186\/cc10457","volume":"15","author":"JF Wu","year":"2011","unstructured":"Wu JF, Ma J, Chen J, Ou-Yang B, Chen MY, Li LF, Liu YJ, Lin AH, Guan XD. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis. Crit Care. 2011;15:R220.","journal-title":"Crit Care"},{"key":"1977_CR14","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1186\/cc13150","volume":"17","author":"MA Cazalis","year":"2013","unstructured":"Cazalis MA, Friggeri A, Cav\u00e9 L, Demaret J, Barbalat V, Cerrato E, Lepape A, Pachot A, Monneret G, Venet F. Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care. 2013;17:R287.","journal-title":"Crit Care."},{"key":"1977_CR15","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/blood.V82.10.3170.3170","volume":"82","author":"G Fingerle","year":"1993","unstructured":"Fingerle G, Pforte A, Passlick B, Blumenstein M, Str\u00f6bel M, Ziegler-Heitbrock HW. The novel subset of CD14+\/CD16+ blood monocytes is expanded in sepsis patients. Blood. 1993;82:3170\u20136.","journal-title":"Blood."},{"key":"1977_CR16","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/01.CCM.0000148008.99716.9C","volume":"32","author":"H Rahman","year":"2004","unstructured":"Rahman H, Salter G, Holmfield H, Larvin M, McMahon MJ. Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260T CD14 genotype are associated with severe acute pancreatitis. Crit Care Med. 2004;32:2457\u201363.","journal-title":"Crit Care Med."},{"key":"1977_CR17","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"KL Wong","year":"2011","unstructured":"Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, Kourilsky P, Wong SC. Gene expression profiling reveals the defining feature of the classical, intermediate, and nonclassical human monocyte subset. Blood. 2011;118:e16\u201331.","journal-title":"Blood."},{"key":"1977_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13054-017-1625-1","volume":"21","author":"N Antonakos","year":"2017","unstructured":"Antonakos N, Tsaganos T, Oberle V, Tsangaris I, Lada M, Pistiki A, Machairas N, Souli M, Bauer M, Giamarellos-Bourboulis EJ. Decreased production by mononuclear cells after severe gram-negative infections: early clinical sings and associations with final outcome. Crit Care. 2017;21:48.","journal-title":"Crit Care."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-1977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T22:53:35Z","timestamp":1603925615000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-1977-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1977"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-1977-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,3]]},"assertion":[{"value":"23 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study constitutes a substudy of a large prospective randomized clinical trial (registration NCT012236690). The study was approved by the ethics committee of \u201cATTIKON\u201d University Hospital (266\/27-07-9). Patients were enrolled after written informed consent provided by themselves or by their legal representative for patients unable to consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients or legal representatives consented to the publication of clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EJGB has received honoraria for providing scientific advice to AbbVie (Chicago IL, USA), Astellas (Athens, Greece), Biotest AG (Dreieich, Germany), and ThermoFisher Scientific GmbH (Henningdorf, Germany). He has received unrestricted educational funding from Biotest AG, ThermoFisher Scientific GmbH, Sanofi SA, (Athens, Greece), the Seventh Framework European Program HemoSpec, and the Horizon 2020 Marie-Curie grant European Sepsis Academy. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"56"}}